As of Nov 25
| +0.19 / +9.50%|
The 4 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 3.63, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +65.53% increase from the last price of 2.19.
The current consensus among 4 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.